Aligos Therapeutics, Inc. Made Headway
Mon, Aug 10, 2026 at 07:36 PM
Aligos Therapeutics, Inc. (ALGS:NASDAQ) soared at $7.65, representing a gain of 36.9%. On Mon, Aug 10, 2026, ALGS:NASDAQ touched a New 2-Week High of $7.65. The stock appeared on our News Catalysts scanner on Fri, Aug 07, 2026 at 03:02 AM in the 'EARNINGS' category. From Mon, Jul 27, 2026, the stock recorded 70.00% Up Days and 72.73% Green Days
About Aligos Therapeutics, Inc. (ALGS:NASDAQ)
Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company.
Top 10 Gainers:
- Socket Mobile, Inc. (SCKT:NASDAQ), 451.67%
- Jowell Global Ltd. (JWEL:NASDAQ), 158.06%
- Steakholder Foods Ltd. (STKH:NASDAQ), 128.72%
- Auddia Inc. (AUUD:NASDAQ), 60.54%
- Bowman Consulting Group Ltd. (BWMN:NASDAQ), 55.78%
- TEN Holdings, Inc. (XHLD:NASDAQ), 53.96%
- Varex Imaging Corporation (VREX:NASDAQ), 48.75%
- MarineMax, Inc. (HZO:NYSE), 46.08%
- Aligos Therapeutics, Inc. (ALGS:NASDAQ), 36.85%
- Jin Medical International Ltd. (ZJYL:NASDAQ), 35.81%